These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29467430)

  • 21. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autochthonous dengue virus infection in Japan imported into Germany, September 2013.
    Schmidt-Chanasit J; Emmerich P; Tappe D; Gunther S; Schmidt S; Wolff D; Hentschel K; Sagebiel D; Schoneberg I; Stark K; Frank C
    Euro Surveill; 2014 Jan; 19(3):. PubMed ID: 24480059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of serum neutralizing antibody response in patients with primary dengue virus type 1 infection].
    Hu D; Li J; Wang D; DI B; Qiu L; Wang Y; Ding X; Che X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1773-6, 1791. PubMed ID: 23268408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.
    Ito M; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2010 Oct; 155(10):1617-24. PubMed ID: 20644969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Trans R Soc Trop Med Hyg; 2013 Jan; 107(1):51-8. PubMed ID: 23296697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.
    Acosta EG; Bartenschlager R
    Expert Rev Vaccines; 2016; 15(4):467-82. PubMed ID: 26577689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus.
    Moi ML; Ami Y; Shirai K; Lim CK; Suzaki Y; Saito Y; Kitaura K; Saijo M; Suzuki R; Kurane I; Takasaki T
    Am J Trop Med Hyg; 2015 Feb; 92(2):370-6. PubMed ID: 25548383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
    Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
    J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.
    Bischof GF; Magnani DM; Ricciardi M; Shin YC; Domingues A; Bailey VK; Gonzalez-Nieto L; Rakasz EG; Watkins DI; Desrosiers RC
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection dynamics of sylvatic dengue virus in a natural primate host, the African Green Monkey.
    Hanley KA; Guerbois M; Kautz TF; Brown M; Whitehead SS; Weaver SC; Vasilakis N; Marx PA
    Am J Trop Med Hyg; 2014 Oct; 91(4):672-6. PubMed ID: 25092823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of dengue NS1 antigen detection tests with acute sera from patients infected with dengue virus in Venezuela.
    Ramirez AH; Moros Z; Comach G; Zambrano J; Bravo L; Pinto B; Vielma S; Cardier J; Liprandi F
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):247-53. PubMed ID: 19733994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does prior dengue virus exposure worsen clinical outcomes of Zika virus infection? A systematic review, pooled analysis and lessons learned.
    Masel J; McCracken MK; Gleeson T; Morrison B; Rutherford G; Imrie A; Jarman RG; Koren M; Pollett S
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007060. PubMed ID: 30682026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mast cell-macrophage dynamics in modulation of dengue virus infection in skin.
    Chu YT; Wan SW; Anderson R; Lin YS
    Immunology; 2015 Sep; 146(1):163-72. PubMed ID: 26059780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
    Ergünay K; Saygan MB; Aydoğan S; Litzba N; Niedrig M; Pınar A; Us D
    Mikrobiyol Bul; 2010 Jul; 44(3):415-24. PubMed ID: 21063991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dengue virus infection in a traveller returning from Croatia to Germany.
    Schmidt-Chanasit J; Haditsch M; Schoneberg I; Gunther S; Stark K; Frank C
    Euro Surveill; 2010 Oct; 15(40):. PubMed ID: 20946759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain.
    Grifoni A; Angelo M; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Botten J; Boyson J; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection.
    Clapham HE; Rodriguez-Barraquer I; Azman AS; Althouse BM; Salje H; Gibbons RV; Rothman AL; Jarman RG; Nisalak A; Thaisomboonsuk B; Kalayanarooj S; Nimmannitya S; Vaughn DW; Green S; Yoon IK; Cummings DA
    J Infect Dis; 2016 May; 213(9):1428-35. PubMed ID: 26704615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting the human serum antibody response to secondary dengue virus infections.
    Patel B; Longo P; Miley MJ; Montoya M; Harris E; de Silva AM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005554. PubMed ID: 28505154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.
    Tricou V; Minh NN; Farrar J; Tran HT; Simmons CP
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1309. PubMed ID: 21909448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.